연구성과로 돌아가기

2025 연구성과별 연구자 정보 (944 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Minks, Eduard Minks, E 9 St Annes Hosp, Brno, Czech Republic sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Park, Jin-Sung Park, JS 10 Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Grudniak, Mariusz Grudniak, M 11 Ctr Med NeuroProtect, Warsaw, Poland sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Smilowski, Marek Smilowski, M 12 Upper Silesian Med Ctr, Katowice, Poland sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Sevilla, Teresa Sevilla, T 13 Hosp Univ & Politecn, Dept Hematol & Med Oncol, Valencia, Spain sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Sevilla, Teresa Sevilla, T 13 IIS La Fe, Valencia, Spain sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Sevilla, Teresa Sevilla, T 13 Univ Valencia, Valencia, Spain sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Hoffmann, Sarah Hoffmann, S 14 Charite, Neurosci Clin Res Ctr NCRC, Dept Neurol, Berlin, Germany AAV-9916-2021 Hoffmann, Sarah 0000-0001-9549-2594 Hoffmann, Sarah sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Hoffmann, Sarah Hoffmann, S 14 Charite, Integrated Myasthenia Gravis Ctr, Berlin, Germany AAV-9916-2021 Hoffmann, Sarah 0000-0001-9549-2594 Hoffmann, Sarah sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Hoffmann, Sarah Hoffmann, S 14 Free Univ Berlin, Berlin, Germany AAV-9916-2021 Hoffmann, Sarah 0000-0001-9549-2594 Hoffmann, Sarah sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Hoffmann, Sarah Hoffmann, S 14 Humboldt Univ, Berlin, Germany AAV-9916-2021 Hoffmann, Sarah 0000-0001-9549-2594 Hoffmann, Sarah sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Sivakumar, Kumaraswamy Sivakumar, K 15 Neuromuscular Res Ctr, Phoenix, AZ 85028 USA sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Sivakumar, Kumaraswamy Sivakumar, K 15 Neuromuscular Clin Arizona, Phoenix, AZ USA sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Suzuki, Yasushi Suzuki, Y 16 Natl Hosp Org, Sendai Med Ctr, Sendai, Japan sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Youssef, Eriene Youssef, E 17 Janssen Res & Dev, Titusville, NJ 08560 USA sramcha4@its.jnj.com;
페이지 이동: